top of page

Postmarket Drug Safety: The View From the FDA

This module is intended for primary care physicians, obstetrician-gynecologists, nurses, pharmacists, and other clinicians.

Upon completion of this activity, participants will be able to:

  1. FDA’s Sentinel Initiative

  2. Understand the FDA Drug safety procedure.

  3. Role of MedWatch

  4. FDAA


Comments

Rated 0 out of 5 stars.
No ratings yet

Add a rating
Nurse Talking to Patient
  • LinkedIn
  • Facebook
  • Twitter
  • Instagram
© Copyright CHEARS®™
Subscribe to Our Newsletter

You are now subscribed to CHEARS

bottom of page